main content start
Mounjaro (tirzepatide) is a once-weekly injectable prescription medication to lower blood glucose, promote weight loss, and reduce heart risk along with physical activity and healthy eating. Through targeting two receptors, the medication works to manage blood glucose through multiple mechanisms, including increasing insulin release, reducing glucagon, and slowing gastric emptying (thus decreasing food intake).
Mounjaro is approved for adults and children 10 years and over with type 2 diabetes.
- Approved for adults and children 10 years and over with type 2 diabetes.
- Weekly injections taken via subcutaneous injection.
- Use can result in significant weight loss. Tirzepatide is separately approved under the brand name Zepbound to treat obesity.
- Reduces risk for heart attack and stroke.
- Common side effects include nausea, injection site reactions, and diarrhea or constipation.
Mounjaro Specs
Key specification
Generic Name
Tirzepatide
Approved for Kids
10+ with type 2 diabetes
Drug Class
Dual GIP/GLP-1 receptor agonists
Type
Injected
General Information
Product Name
Mounjaro
Product Type
Injectable Medications
Brand
Eli Lilly and Co.
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
